International Workshop on Clinical Pharmacology of Tuberculosis Drugs 2017

Organizing Committee

The members of the Organizing Committee (OC) discuss, on a frequent basis, the scientific program of the workshop, identify interesting topics and candidate speakers and review all submitted abstracts.

Scientific Committee

The members of Scientific Committee assist the OC by providing them with suggestions for speakers and topics. In addition, members of the Scientific Committee actively participate in reviewing submitted abstracts.

• Jan-Willem Alffenaar, PhD, PharmD UMCG, The Netherlands
• Deron Burton CDC, USA
• Dakshina Chilukuri, PhD FDA, USA
• Véronique Dartois, PhD Rutgers, The State University of New Jersey, Newark, USA
• Paolo Denti, PhD University of Cape Town, South Africa
• Kelly Dooley, MD, PhD Johns Hopkins University, USA
• Tawanda Gumbo, MD Baylor Institute for Immunology Research, USA
• Richard Hafner, MD National Institutes of Health, USA
• Scott Heysell, MD, MPH University of Virginia, USA
• Anneke Hesseling, MD Desmond Tutu Tuberculosis Centre, South Africa
• Russell Kempker, MD, MSc Emory University School of Medicine, USA
• Steven Kern, PhD Bill & Melinda Gates Foundation, USA
• Christian Lienhardt, MD, PhD WHO – Stop TB Department, Switzerland
• Rovina Ruslami, MD, PhD Padjadjaran University, Indonesia
• Ulrika Simonsson, PharmD, PhD Uppsala University, Sweden
• Susan Swindells, MBBS University of Nebraska Medical Center, USA
• Andrew Vernon, MD CDC, TBTC, USA
• Robert Wallis, MD, FIDSA The Aurum Institute, South Africa